المؤلفون: Andrea Varga, Antoine Hollebecque, Rastilav Bahleda, Anas Gazzah, Christophe Massard, Sandrine Aspeslagh, Jean-Charles Soria, Anna Spreafico, Michele Reni, Kunwar Shailubhai

المساهمون: Medical Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, Antimetabolites, Antineoplastic/administration & dosage, Carcinoma, Non-Small-Cell Lung/drug therapy, Toxicology, Deoxycytidine, Gastroenterology, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Pharmacology (medical), Drug Interactions, Middle Aged, Cyclin-Dependent Kinases, Treatment Outcome, Tolerability, 030220 oncology & carcinogenesis, Peritoneal mesothelioma, Female, medicine.drug, Antimetabolites, Antineoplastic, medicine.medical_specialty, Maximum Tolerated Dose, Neutropenia, Cyclin-Dependent Kinases/antagonists & inhibitors, 03 medical and health sciences, Refractory, Pharmacokinetics, Internal medicine, medicine, Humans, Lung Neoplasms/drug therapy, Deoxycytidine/administration & dosage, Aged, Pharmacology, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, medicine.disease, Pyrazoles/administration & dosage, Gemcitabine, Quinazolines/administration & dosage, Neoplasms/drug therapy, Regimen, 030104 developmental biology, Drug Resistance, Neoplasm, Concomitant, Quinazolines, Pyrazoles, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42306b90b467bedc036686d59e41b35d
https://hdl.handle.net/20.500.14017/91e1653b-3c7b-4d0b-abd1-66ca3def9be4